- CSR Summary Not Yet Available
- NCT Number Not Available
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameTrabectedinProduct NameYONDELIS®Therapeutic AreaCancers and Other NeoplasmsEnrollment50% Female55.5%% WhiteN/A
Product ClassAntineoplastic AgentsSponsor Protocol NumberET-B-008-98Data PartnerJohnson & JohnsonCondition StudiedSarcomaMean/Median Age (Years)48
Supporting Documentation
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the annotated CRF, protocol, statistical analysis plan, and full clinical study report are available.